Judah Folkman: Tumor angiogenesis. Adv. Cancer Res. 19 (1974), 331-358.

Judah Folkman: The vascularization of tumors.
Sci. Am. 234 (1976), 58-73.

Judah Folkman: The vascularization of tumors.
In Friedberg 1986, 115-124.

Judah Folkman: Tumor angiogenesis.
In Mendelsohn/Howley/Israel/Liotta 1995, ...

Judah Folkman/M. Klagsbrun: Angiogenic factors. Science 235 (1987), 442-447.

Judah Folkman/E. Merler/C. Abernathy/G. Williams: Isolation of tumor
factor responsible for angiogenesis.
J. Exp. Med. 113 (1971), 275-...

Judah Folkman/Y. Shing: Angiogenesis. J. Biol. Chem. 267 (1992), 10931-...

E. Friedberg (ed.): Cancer biology. Readings from Scientific American.
Scientific American 1986.

M. Gimbrone/R. Cotran/S. Leapman/Judah Folkman: Tumor growth and
neovascularization - an experimental model using the rabbit cornea.
J. Nat. Cancer Inst. 52 (1974), 413-427.

P. Gullino: Angiogenesis and oncogenesis.
J. Nat. Cancer Inst. 61 (1978), 639-...

14506 Tamara Konopka a.o.: Nitric oxide synthase II gene disruption -
implications for tumor growth and vascular endothelial growth factor
production. Cancer Res. 61 (2001), 3182-3187.

J. Mendelsohn/P. Howley/Israel/L. Liotta (ed.): The molecular basis of
cancer. Saunders 1995.

V. Muthukkaruppan/L. Kubai/R. Auerbach: Tumour-induced neovascularization
in the mouse eye. J. Nat. Cancer Res. 69 (1982), 699-705.

Michael O'Reilly/L. Holmgren/C. Chen/Judah Folkman: Angiostatin induces
and sustains dormancy of human primary tumors in mice.
Nature Medicine 2/6 (1996), 689-692.

N. Paweletz/M. Knierim: Tumour-related angiogenesis.
Critical Rev. Oncology/Hematology 9 (1989), 197-242.

K. Plate/G. Breier/H. Weich/W. Risau: Vascular endothelial growth factor
is a potential tumour angiogenesis factor in human gliomas in vivo.
Nature 359 (1992), 845-...

B. Teicher a.o.: Antiangiogenic agents can increase tumor oxygenation
and response to radiation therapy.
Radiation Oncology Inv. 2/6 (1995), 269-276.

20252 ZZ: Krise im Müll. Spiegel 10. April 1972, 158.
Judah Folkmans entdeckt die Bedeutung der Angiogenese.
Ein gutes Beispiel dafür, wie wenig die Krebsforschung vorangekommen ist.
Der Grund ist wohl, daß sich in den letzten 30 Jahren die Forscher
auf das Publizieren und gegenseitige Literaturrefereate konzentriert haben,
statt auf vernünftige und systematische Forschung.